Search the collection

3 results for Kerbrat,+Pierre,+Prof

Sort by:

Sort by

Limit results to:

20 per page

3 results for Kerbrat,+Pierre,+Prof

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
Author / Creator:Pivot, Xavier, Prof ; Romieu, Gilles, MD ; Debled, Marc, MD ; Pierga, Jean-Yves, Prof ; Kerbrat, Pierre, Prof ; Bachelot, Thomas, MD ; Lortholary, Alain, MD ; Espié, Marc, MD ; Fumoleau, Pierre, Prof ; Serin, Daniel, MD ; Jacquin, Jean-Philippe, MD ; Jouannaud, Christelle, MD ; Rios, Maria, MD ; Abadie-Lacourtoisie, Sophie, MD ; Tubiana-Mathieu, Nicole, Prof ; Cany, Laurent, MD ; Catala, Stéphanie, MD ; Khayat, David, Prof ; Pauporté, Iris, PhD ; Kramar, Andrew, PhD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2013-07, Vol.14 (8), p.741-748
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
Author / Creator:Fizazi, Karim, Prof ; Pagliaro, Lance, Prof ; Laplanche, Agnes, MD ; Fléchon, Aude, MD ; Mardiak, Josef, Prof ; Geoffrois, Lionnel, MD ; Kerbrat, Pierre, Prof ; Chevreau, Christine, MD ; Delva, Remy, MD ; Rolland, Frederic, MD ; Theodore, Christine, MD ; Roubaud, Guilhem, MD ; Gravis, Gwenaëlle, MD ; Eymard, Jean-Christophe, MD ; Malhaire, Jean-Pierre, MD ; Linassier, Claude, Prof ; Habibian, Muriel ; Martin, Anne-Laure ; Journeau, Florence ; Reckova, Maria, MD ; Logothetis, Christopher, Prof ; Culine, Stephane, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2014-12, Vol.15 (13), p.1442-1450
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study
Author / Creator:Bertucci, François, Prof ; Fekih, Mahmoud, MD ; Autret, Aurélie, MSc ; Petit, Thierry, Prof ; Dalenc, Florence, MD ; Levy, Christelle, MD ; Romieu, Gilles, MD ; Bonneterre, Jacques, Prof ; Ferrero, Jean-Marc, Prof ; Kerbrat, Pierre, Prof ; Soulie, Patrick, MD ; Mouret-Reynier, Marie-Ange, MD ; Bachelot, Thomas, MD ; Lerebours, Florence, MD ; Eymard, Jean-Christophe, MD ; Deblock, Mathilde, MD ; Lortholary, Alain, MD ; Hardy-Bessard, Anne-Claire, MD ; Barthelemy, Philippe, MD ; Bonnefoi, Hervé, Prof ; Charafe-Jauffret, Emmanuelle, Prof ; Bidard, François-Clément, MD ; Viens, Patrice, Prof ; Lemonnier, Jérôme, PhD ; Pierga, Jean-Yves, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2016-05, Vol.17 (5), p.600-611
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Export this record

Export record to excel

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial

Export this record

Export record to excel

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study

Refine your search